537
Views
13
CrossRef citations to date
0
Altmetric
Review

Aromatase inhibitors for the treatment of endometriosis: a systematic review about efficacy, safety and early clinical development

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 1377-1388 | Received 29 May 2020, Accepted 22 Oct 2020, Published online: 26 Nov 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Panagiotis Peitsidis, Panagiotis Tsikouras, Antonio Simone Laganà, Alexandros Laios, Ioannis D Gkegkes & Christos Iavazzo. (2023) A Systematic Review of Systematic Reviews on the Use of Aromatase Inhibitors for the Treatment of Endometriosis: The Evidence to Date. Drug Design, Development and Therapy 17, pages 1329-1346.
Read now
Barbara Gardella, Edoardo Rispoli, Marianna Francesca Pasquali, Matteo Mauri, Valentina Musacchi & Mattia Dominoni. (2023) Aromatase inhibitors in the pharmacotherapy of endometriosis. Expert Opinion on Pharmacotherapy 24:9, pages 1067-1073.
Read now
Sara Clemenza, Silvia Vannuccini, Agostino Ruotolo, Tommaso Capezzuoli & Felice Petraglia. (2022) Advances in targeting estrogen synthesis and receptors in patients with endometriosis. Expert Opinion on Investigational Drugs 31:11, pages 1227-1238.
Read now
Antonio Cianci & Salvatore Giovanni Vitale. (2022) D-Chiro-inositol and PCOS: between myth and reality. The never-ending story. International Journal of Food Sciences and Nutrition 73:5, pages 565-570.
Read now
Susan Dababou, Simone Garzon, Antonio Simone Laganà, Simone Ferrero, Giulio Evangelisti, Marco Noventa, Maurizio Nicola D’Alterio, Stefano Palomba, Stefano Uccella, Massimo Franchi & Fabio Barra. (2021) Linzagolix: a new GnRH-antagonist under investigation for the treatment of endometriosis and uterine myomas. Expert Opinion on Investigational Drugs 30:9, pages 903-911.
Read now

Articles from other publishers (8)

Bahi ElbasuenyMaya Geerts, Emily C. Yang, Catherine Allaire, Paul J. Yong & Mohamed A. Bedaiwy. (2022) Medical treatments of endometriosis: a review. Reproductive and Developmental Medicine 7:3, pages 166-179.
Crossref
Sundus Nawaz, Sadia Habib, Saba Ayoub, Ghazala Shams, Nimra Naeem & Ruqiya Sultana. (2022) Comparison of The Efficacy of Letrozole Versus Danazol in Pain Relief in Endometriosis. Pakistan Journal of Health Sciences, pages 248-252.
Crossref
Mislav Mikuš, Marina Šprem Goldštajn, Ivan Brlečić, Stipe Dumančić, Antonio Simone Laganà, Vito Chiantera, Goran Vujić & Mario Ćorić. (2022) CTLA4-Linked Autoimmunity in the Pathogenesis of Endometriosis and Related Infertility: A Systematic Review. International Journal of Molecular Sciences 23:18, pages 10902.
Crossref
Milena Králíčková, Vaclav Vetvicka, Luděk Fiala, Antonio Simone Laganà & Simone Garzon. (2021) The Search for Biomarkers in Endometriosis: a Long and Windy Road. Reproductive Sciences 29:6, pages 1667-1673.
Crossref
Simone Ferrero & Fabio Barra. 2022. Endometriosis and Adenomyosis. Endometriosis and Adenomyosis 557 575 .
Kent Yu-Hsien Lin, Chih-Yi Yang, Alan Lam, Cherry Yin-Yi Chang & Wu-Chou Lin. (2021) Uterine leiomyoma is associated with the risk of developing endometriosis: A nationwide cohort study involving 156,195 women. PLOS ONE 16:8, pages e0256772.
Crossref
Luca Pinzi, Annachiara Tinivella, Luca Gagliardelli, Domenico Beneventano & Giulio Rastelli. (2021) LigAdvisor: a versatile and user-friendly web-platform for drug design. Nucleic Acids Research 49:W1, pages W326-W335.
Crossref
Abdulkarim Hasan, Abdou Deyab, Khaled Monazea, Abdoh Salem, Zahraa Futooh, Mahmoud A. Mostafa, Ahmed Youssef, Mohamed Nasr, Nasser Omar, Ali A. Rabaan & Doha M. Taie. (2021) Clinico-pathological assessment of surgically removed abdominal wall endometriomas following cesarean section. Annals of Medicine and Surgery 62, pages 219-224.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.